The α1β1 and α2β1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis

American Journal of Pathology

Volumn 160, Issue 1, 2002, Pages 195-204

  Senger, Donald R ^a   Perruzzi, Carole A ^a   Streit, Michael ^b   Koteliansky, Victor E ^c   De Fougerolles, Antonin R ^c   Detmar, Michael ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CYTOKINE; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT;

EID: 0036142782     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64363-5     Document Type: Article

References (48)

1. Vascular permeability factor (VPF, VEGF) in tumor biology
2. The role of vascular endothelial growth factor in pathological angiogenesis
3. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
4. Endothelial receptor tyrosine kinases involved in angiogenesis
5. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
6. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
7. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor
8. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
9. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
10. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
11. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
12. Vascular endothelial growth factor/vascular permeability factor: Multiple biological activities for promoting angiogenesis
13. Integrins, adhesion and apoptosis
14. Integrin signaling
15. Anchorage-dependent regulation of the mitogen-activated protein kinase cascade by growth factors is supported by a variety of integrin alpha chains
16. Integrins: Versatility, modulation, and signaling in cell adhesion
17. Integrins
18. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins
19. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin
20. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
21. Glomerular epithelial and mesangial cells differentially modulate the binding specificities of VLA-1 and VLA-2
22. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
23. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas
24. The MAPK signaling cascade
25. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity
26. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium
27. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
28. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth
29. Cell anchorage permits efficient signal transduction between ras and its downstream kinases
30. Growth factor activation of MAP kinase requires cell adhesion
31. Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase
32. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase
33. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
34. Collagen and elastin of human dermis
35. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
36. VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation
37. An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix
38. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization
39. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
40. Definition of two angiogenic pathways by distinct alpha v integrins
41. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization
42. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin
43. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
44. Targeted mutations in integrins and their ligands: Their implications for vascular biology
45. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins
46. Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1 integrin can be replaced by alpha V integrins
47. Trans-dominant inhibition of integrin function
48. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis